Скачать с ютуб EHA Topics in focus : Immunotherapy в хорошем качестве

EHA Topics in focus : Immunotherapy

Prof John Gribbin speaks at EHA about the development of a dedicated education programme for immunotherapy as a key topic, especially the current and future indications of CAR-T cells. He outlines the difference in access and development of CAR-T therapies between the US and Europe, and the economic factors that may drive cost and clinical development of further research. Prof Gribbin emphasises the place of ongoing education for clinicians, patients and policy makers in understanding and influencing the course of development. For more on this, watch his interview with ecancer here. ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.